SI1295129T1 - Diferencialna diagnoza nevroloških bolezni - Google Patents

Diferencialna diagnoza nevroloških bolezni

Info

Publication number
SI1295129T1
SI1295129T1 SI200130970T SI200130970T SI1295129T1 SI 1295129 T1 SI1295129 T1 SI 1295129T1 SI 200130970 T SI200130970 T SI 200130970T SI 200130970 T SI200130970 T SI 200130970T SI 1295129 T1 SI1295129 T1 SI 1295129T1
Authority
SI
Slovenia
Prior art keywords
individual suffering
versus
differential diagnosis
disease
neurological diseases
Prior art date
Application number
SI200130970T
Other languages
English (en)
Inventor
Eugeen Vanmechelen
Hugo Vanderstichele
Frank Hulstaert
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of SI1295129T1 publication Critical patent/SI1295129T1/sl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SI200130970T 2000-06-30 2001-06-21 Diferencialna diagnoza nevroloških bolezni SI1295129T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP00870151 2000-06-30
US21890700P 2000-07-18 2000-07-18
PCT/EP2001/007029 WO2002003073A1 (en) 2000-06-30 2001-06-21 Differential diagnosis of neurological diseases
EP01957875A EP1295129B1 (en) 2000-06-30 2001-06-21 Differential diagnosis of neurological diseases

Publications (1)

Publication Number Publication Date
SI1295129T1 true SI1295129T1 (sl) 2010-08-31

Family

ID=45540530

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130970T SI1295129T1 (sl) 2000-06-30 2001-06-21 Diferencialna diagnoza nevroloških bolezni

Country Status (11)

Country Link
EP (1) EP1295129B1 (sl)
JP (1) JP4851052B2 (sl)
AT (1) ATE463745T1 (sl)
AU (2) AU7967801A (sl)
CA (1) CA2411584C (sl)
DE (1) DE1295129T1 (sl)
DK (1) DK1295129T3 (sl)
ES (1) ES2343510T3 (sl)
PT (1) PT1295129E (sl)
SI (1) SI1295129T1 (sl)
WO (1) WO2002003073A1 (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1583503A4 (en) * 2002-12-20 2006-08-09 Biogen Idec Inc POLYVALENT LYMPHOTOXIN BETA RECEPTOR AGONISTS AND THERAPEUTIC USE THEREOF
US8506933B2 (en) 2007-11-30 2013-08-13 Msdx, Inc. Methods of detecting a neurological condition via analysis of circulating phagocytes
US8673309B2 (en) 2011-02-11 2014-03-18 Msdx, Inc. Methods for measuring high molecular weight complexes of fibrinogen with fibronectin and fibulin-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733734A (en) * 1991-08-14 1998-03-31 The Trustees Of The University Of Pennsylvania Method of screening for Alzheimer's disease or disease associated with the accumulation of paired helical filaments
JPH07132033A (ja) * 1993-11-12 1995-05-23 Hoechst Japan Ltd アルツハイマー病モデルトランスジェニック動物
CA2178212C (en) * 1993-12-21 2011-06-14 Marc Vandermeeren Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications
JP2000253774A (ja) * 1999-03-12 2000-09-19 Mitsubishi Chemicals Corp タウ蛋白のリン酸化が亢進された実験用マウス

Also Published As

Publication number Publication date
ES2343510T3 (es) 2010-08-03
EP1295129A1 (en) 2003-03-26
EP1295129B1 (en) 2010-04-07
CA2411584C (en) 2012-07-24
AU2001279678B2 (en) 2005-08-18
JP2004502939A (ja) 2004-01-29
DK1295129T3 (da) 2010-07-12
WO2002003073A1 (en) 2002-01-10
DE1295129T1 (de) 2003-06-26
CA2411584A1 (en) 2002-01-10
AU7967801A (en) 2002-01-14
JP4851052B2 (ja) 2012-01-11
PT1295129E (pt) 2010-06-21
ATE463745T1 (de) 2010-04-15

Similar Documents

Publication Publication Date Title
CY1110195T1 (el) Διαφορικη διαγνωση νευρολογικων νοσων
JO2359B1 (en) Benzathene derivatives as agents for modulation of GABA A receptor
EP1165086A4 (en) BUPROPION METABOLITES AND METHOD FOR THE PRODUCTION AND USE THEREOF
BG66103B1 (bg) Кондензирани пиролокарбазоли
MXPA02011373A (es) Derivados de triazol.
HK1087628A1 (en) Prodrugs of gaba analogs, compositions and uses thereof gaba
HK1060843A1 (en) Combination of an epothilone analog and chemotherapeutic agents for the treatment of proliferative diseases
IL146631A0 (en) Diagnostics and therapeutics for cardiovascular disorders
AU2002252373A1 (en) Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
IL132153A0 (en) Novel compounds
WO2003020212A3 (en) Treatment for central nervous system disorders
BG101110A (en) Substituted pyrimidine compounds and their application
TWI265928B (en) A61k 31/4025 200601 a i htw a61p 25/00 200601 a n htw
MY124786A (en) Bis-arylsulfones
BG106509A (en) Preparative form
EP2277528A3 (en) Use of VEGF and homologues to treat neuron disorders
DE60227517D1 (de) Verfahren zur herstellung von 10,11 dihydro 10 hydroxy 5h-dibenz/b,f/azepin-5-carbonsäureamid und 10,11 dihydro 10 oxo-5h-dibenz/b,f/azepin-5 carbonsäureamid
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
AU7967801A (en) Differential diagnosis of neurological diseases
AU2002227895A1 (en) Sulphonamides for the treatment of central nervous system diseases
BG103649A (en) Method for the preparation of eprosartan
BG102707A (en) New triazolopurinpurines, method for their preparation and appplication as medicamentous forms
PL331321A1 (en) Treatment pf psychotic disorders
TWI245756B (en) Improved process for the preparation of 1,3-substituted indenes
EP1414457A4 (en) CHIRAL DINAPSOLIN